Skip to content
(614)355-5560
West Region
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids

Since the discontinuation of brand name Flovent®, there have been many challenges with patient access to spacer-compatible inhaled steroids that are appropriate for children with asthma. Even though fluticasone propionate HFA (authorized generic of Flovent®), is a covered option for Ohio Medicaid patients, there still may be shortages at the pharmacy to overcome. In response, Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children.  Included in this resource is standard language that will assist with proper communication to insurance companies if a prior authorization is requested. 

If you have questions, please reach out to the Partners For Kids pharmacy team at PFKPharmacy@ChildrensDayton.org

Related Articles
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
April 3, 2024
Quarterly Update for Partners For Kids Pediatric-Focused Unified Preferred Drug List (UPDL)
Read More
Pharmacy Updates
March 5, 2024
Updated Attention Deficit Hyperactivity Disorder (ADHD) Guidelines are Now Available – Central Region
Resources within the guideline include screening tools, treatment algorithms, and medication dosing recommendations.
Read More
Pharmacy Updates
March 5, 2024
A New Tool to Overcome Access Barriers to Spacer-Compatible Inhaled Steroids
Partners For Kids has created a pathway to guide decision-making when prescribing inhaled steroids for children. 
Read More
Pharmacy Updates
February 15, 2024
Updated Nicotine Dependence Prescribing Guidelines Now Available
Topics include screening and diagnostic tools, first-line behavioral modifications and external support, recommended medication and nicotine replacement therapies, and treatment time frame recommendations.
Read More
Pharmacy Updates
February 15, 2024
Updated Nicotine Dependence Prescribing Guidelines Now Available
Topics include screening and diagnostic tools, first-line behavioral modifications and external support, recommended medication and nicotine replacement therapies, and treatment time frame recommendations.
Read More